1.75
price up icon0.00%   0.00
after-market 시간 외 거래: 1.83 0.08 +4.57%
loading

Regulus Therapeutics Inc (RGLS) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
6.34%
8.826
8.30 8.125 7.315 7.369
Interest Income/Expense
28.95%
0.081
0.114 0.137 0.168 0.185
Operating Income/Loss
6.34%
-8.826
-8.30 -8.125 -7.315 -7.369
Income/Loss From Continuing Operations Before Tax
5.06%
-8.469
-8.061 -7.824 -7.012 -7.139
Income/Loss From Continuing Operations After Tax
5.06%
-8.469
-8.061 -7.824 -7.013 -7.139
Net Income/Loss
5.06%
-8.469
-8.061 -7.824 -7.013 -7.139
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6,661%
28.75
0.4252 19.63 19.10 16.84
Diluted Average Shares
6,661%
28.75
0.4252 19.63 19.10 16.84
Basic Earnings Per Share
110.47%
-0.29
2.77 -0.40 -0.37 -0.42
Diluted Earnings Per Share
110.47%
-0.29
2.77 -0.40 -0.37 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
자본화:     |  볼륨(24시간):